Nova Reader - Subject https://www.novareader.co Default RSS Feed en-us Newgen KnowledgeWorks <![CDATA[Minimal change disease relapse following SARS-CoV-2 mRNA vaccine]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.033 <![CDATA[Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19–recovered patients who received a kidney transplant]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.018 <![CDATA[Acute rejection after anti–SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.025 <![CDATA[A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.024 <![CDATA[Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.005 <![CDATA[Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.006 <![CDATA[Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.010 <![CDATA[Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.008 <![CDATA[SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.03.032 <![CDATA[Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.04.009 <![CDATA[Zero health care–associated respiratory viral infections: impact of enhanced infection prevention on a renal unit during the coronavirus disease 2019 pandemic]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.02.020 <![CDATA[Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.02.015 <![CDATA[Glomerular basement membrane nephritis: crescentic renal inflammation and immunosuppressive intervention in the time of the severe acute respiratory syndrome coronavirus 2 pandemic]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.02.004 <![CDATA[High rates of long-term renal recovery in survivors of coronavirus disease 2019–associated acute kidney injury requiring kidney replacement therapy]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.01.005 <![CDATA[Two episodes of severe acute respiratory syndrome coronavirus 2 infection in a patient on chronic hemodialysis: a note of caution]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2021.01.003 <![CDATA[Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2020.12.027 <![CDATA[Decline and loss of anti–SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2020.12.001 <![CDATA[Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2020.11.014 <![CDATA[Corroborating evidence refutes batch effect as explanation for fetal bacteria]]> https://www.novareader.co/book/isbn/10.1186/s40168-020-00948-0 <![CDATA[Comment on “Conserved phylogenetic distribution and limited antibiotic resistance of class 1 integrons revealed by assessing the bacterial genome and plasmid collection” by A.N. Zhang et al.]]> https://www.novareader.co/book/isbn/10.1186/s40168-020-00950-6 An article published in Microbiome in July 2018 uses incorrect definitions of integron integrase IntI1 and of class 1 integrons that affect the interpretation of the data.

]]> <![CDATA[Batch effects account for the main findings of an in utero human intestinal bacterial colonization study]]> https://www.novareader.co/book/isbn/10.1186/s40168-020-00949-z A recent study by Rackaityte et al. reported evidence for a low level of bacterial colonization, specifically of Micrococcus luteus, in the intestine of second trimester human fetuses. We have re-analyzed their sequence data and identified a batch effect which violates the underlying assumptions of the bioinformatic method used for contamination removal. This batch effect resulted in Micrococcus not being identified as a contaminant in the original work and being falsely assigned to the fetal samples. We further provide evidence that the micrographs presented by Rackaityte et al. are unlikely to show Micrococci or other bacteria as the size of the particles shown exceeds that of related bacterial cells. Finally, phylogenetic analysis showed that the microbes cultured from the fetal samples differed significantly from those detected by sequencing. Overall, our findings show that the presence of Micrococcus in the fetal gut is not supported by the primary sequence data. Our findings underline important aspects of the nature of contamination for both sequencing and culture approaches in microbiome studies and the appropriate use of automated contamination identification tools.

]]> <![CDATA[On the need to better protect hemodialysis patients: a comment on “IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)”]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2020.11.024 <![CDATA[The authors reply]]> https://www.novareader.co/book/isbn/10.1016/j.kint.2020.12.008